Antigenic peptide-tobacco mosaic virus conjugates as a fungal vaccine candidate
Authors:
- 17 September 2024
- journal article
- research article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 245, 114251
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 24 references indexed in Scilit:
- Vaccine delivery systems toward lymph nodesAdvanced Drug Delivery Reviews, 2021
- Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious DiseasesAdvanced NanoBiomed Research, 2020
- Engineering Strategies for Lymph Node Targeted Immune ActivationAccounts of Chemical Research, 2020
- Fungal Infections2020
- Single-wavelength Excited Ratiometric Fluorescence pH Probe to Image Intracellular Trafficking of Tobacco Mosaic VirusChinese Journal of Polymer Science, 2019
- Use of plant viruses and virus-like particles for the creation of novel vaccinesAdvanced Drug Delivery Reviews, 2019
- B Cell Responses: Cell Interaction Dynamics and DecisionsCell, 2019
- Lymph node targeting strategies to improve vaccination efficacyJournal of Controlled Release, 2017
- Chemical Modification of the Inner and Outer Surfaces of Tobacco Mosaic Virus (TMV)2013
- Nanoparticles target distinct dendritic cell populations according to their sizeEuropean Journal of Immunology, 2008